A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers
Clinical trial NCT03751202 · COMPLETED
Trial details
- NCT number
- NCT03751202
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2018-12-11
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.